WANBURY
Back to Cashflow Statement
|
WANBURY Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹0.66 Cr | ₹1.94 Cr | ₹-21 Cr | ₹13 Cr | ₹7.34 Cr |
What is the latest Net Cash Inflow / Outflow ratio of WANBURY ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹0.66 Cr |
| Mar2024 | ₹1.94 Cr |
| Mar2023 | ₹-21 Cr |
| Mar2022 | ₹13 Cr |
| Mar2021 | ₹7.34 Cr |
How is Net Cash Inflow / Outflow of WANBURY Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.66 Cr | -66.07 | |
| Mar2024 | ₹1.94 Cr | Positive | |
| Mar2023 | ₹-21 Cr | Negative | |
| Mar2022 | ₹13 Cr | 70.64 | |
| Mar2021 | ₹7.34 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹932.0 Cr | 3% | 4.7% | -9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,036.0 Cr | 0.8% | -4.2% | 7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,218.0 Cr | 1.1% | -0.7% | -1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,099.0 Cr | 0% | 1.3% | 40.1% | Stock Analytics | |
| CIPLA | ₹110,897.0 Cr | -0.3% | -4.1% | -8.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,591.0 Cr | 0.4% | -4.5% | -5.2% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | 3% |
4.7% |
-9% |
| SENSEX | 3.9% |
1.9% |
-6.8% |
You may also like the below Video Courses